Generic Name |
Imatinib + PDR001 | |
---|---|---|
IND |
||
Brand Name (US) |
||
Manufacturer |
Novartis | |
Drug Type |
KIT + PD-1 inhibitor | |
Delivery |
Oral, Intravenous | |
Approval Status |
||
Indications |
||
Overall Strategy |
KIT Protein and immune system | |
Strategy |
Block KIT + Stimulate the immune system | |
Drug Category |
KIT inhibitor + PD-1 inhibitor |
Links |
|
Trials of this drug |
|
|
PDR001 Plus Imatinib for Metastatic or Unresectable GIST |
Trial results |